Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2026-06-24 21:50:03 ET · period of report 2026-06-22 · accession 0001930732-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-24 21:50 | 2026-06-22 | FBIO | Jin David | CFO | A - Grant | $0.00 | +400.0K | 1.65M | +32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 | 2026-06-22 | A | A | 400,000 | $0.00 | 1,651,571 | D | — | — | (F1) Represents an award of 400,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in four equal annual installments, with the first installment vesting on January 5, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Vested restricted stock units will be settled in shares of the Issuer's common stock. (F2) Total holdings include 1,230,000 shares underlying previously granted deferred restricted stock units. |